Krabbe disease also known as globoid cell leukodystrophy or galactosylceramide lipidosis, is a rare (occurs in about 1 in 100,000–200,000 births), fatal inherited degenerative disorder that affects the nervous system. It is characterized by the presence of globoid cells (cells that have more than one nucleus). Krabbé disease is one of a group of genetic disorders called the leukodystrophies.
Cause :
Krabbe disease is caused by mutations in the GALC gene, which causes deficiency of an enzyme called galactosylceramidase. The buildup of undigested fats affects the growth of the nerve’s protective myelin sheath (the covering that insulates many nerves) and causes severe degeneration of mental and motor skills. Krabbe disease results from the imperfect growth and development of myelin.
Symptoms:
Infants born with Krabbe disease are normal at birth. Symptoms begin between the ages of 3 and 6 months with irritability, excessive crying, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. In the first stages of the disease symptoms include muscle weakness, spasticity, deafness, optic atrophy and blindness, paralysis, and difficulty when swallowing. Prolonged weight loss may also occur.
It is said that the infant suffering from this disease slowly looses control on its nervous system. Because of that one by one all the system of the body stops working.
Treatment:
Although there is no cure for Krabbe disease, bone marrow transplantation has been shown to benefit mild cases early in the course of the disease. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation. A recent study reports that cord blood transplants have been successful in stopping the disease as long as they are given before overt symptoms appear.
But generally that all happens only if the disease has been diagnosed in the very early ages of the infant, say 2-3 months. Only then the above mentioned treatment has a success rate of less than 50% and that too is very very costly. Generally the treatment involving Bone Marrow transplantation costs around $250,000 and even more. Even after that it is not sure the infant will be 100% normal or even live. Studies are going on, but lot more has to be done before any proper treatment or the test gets available.